Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources
出版年份 2015 全文链接
标题
Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources
作者
关键词
-
出版物
DIABETIC MEDICINE
Volume 33, Issue 4, Pages 471-477
出版商
Wiley
发表日期
2015-07-16
DOI
10.1111/dme.12844
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: A 26-week, randomised, treat-to-target trial
- (2015) Shizuka Kaneko et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Comparison of Insulin Degludec/Insulin Aspart and Biphasic Insulin Aspart 30 in Uncontrolled, Insulin-Treated Type 2 Diabetes: A Phase 3a, Randomized, Treat-to-Target Trial
- (2014) Gregory R. Fulcher et al. DIABETES CARE
- Efficacy and safety of insulin degludec given as part of basal-bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomized, open-label, treat-to-target non-inferiority trial
- (2014) M. J. Davies et al. DIABETES OBESITY & METABOLISM
- Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation
- (2014) N Waugh et al. HEALTH TECHNOLOGY ASSESSMENT
- National Trends in US Hospital Admissions for Hyperglycemia and Hypoglycemia Among Medicare Beneficiaries, 1999 to 2011
- (2014) Kasia J. Lipska et al. JAMA Internal Medicine
- National Estimates of Insulin-Related Hypoglycemia and Errors Leading to Emergency Department Visits and Hospitalizations
- (2014) Andrew I. Geller et al. JAMA Internal Medicine
- The Efficacy and Safety of Insulin Degludec Given in Variable Once-Daily Dosing Intervals Compared With Insulin Glargine and Insulin Degludec Dosed at the Same Time Daily: A 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes
- (2013) L. Meneghini et al. DIABETES CARE
- Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naïve Patients With Type 2 Diabetes
- (2013) Stephen C.L. Gough et al. DIABETES CARE
- Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents
- (2013) A. Philis-Tsimikas et al. DIABETES OBESITY & METABOLISM
- Superior glycaemic control with once-daily insulin degludec/insulin aspart versus insulin glargine in Japanese adults with type 2 diabetes inadequately controlled with oral drugs: a randomized, controlled phase 3 trial
- (2013) Y. Onishi et al. DIABETES OBESITY & METABOLISM
- Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries
- (2013) Marc Evans et al. Health and Quality of Life Outcomes
- Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension
- (2013) Chantal Mathieu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Quantifying the Direct and Indirect Costs Associated with Severe and Non-Severe Hypoglycaemia in Subjects with Type-2 Diabetes Who Are Treated with Insulin
- (2013) V. Foos et al. VALUE IN HEALTH
- Insulin degludec compared with insulin glargine in insulin-naïve patients with type 2 diabetes: A 26-week, randomized, controlled, Pan-Asian, treat-to-target trial
- (2013) Yukiko Onishi et al. Journal of Diabetes Investigation
- Descriptions of health states associated with increasing severity and frequency of hypoglycemia: a patient-level perspective
- (2013) Stewart Harris et al. Patient Preference and Adherence
- Insulin Degludec/Insulin Aspart Administered Once Daily at Any Meal, With Insulin Aspart at Other Meals Versus a Standard Basal-Bolus Regimen in Patients With Type 1 Diabetes: A 26-week, phase 3, randomized, open-label, treat-to-target trial
- (2012) I. B. Hirsch et al. DIABETES CARE
- Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)
- (2012) B. Zinman et al. DIABETES CARE
- Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
- (2012) Alan J Garber et al. LANCET
- Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
- (2012) Simon Heller et al. LANCET
- Impaired awareness of hypoglycaemia: a review
- (2011) A.J. Graveling et al. DIABETES & METABOLISM
- Insulin analogues and severe hypoglycaemia in type 1 diabetes
- (2011) P.L. Kristensen et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Emergency Hospitalizations for Adverse Drug Events in Older Americans
- (2011) Daniel S. Budnitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Impact of Non-Severe Hypoglycemic Events on Work Productivity and Diabetes Management
- (2011) Meryl Brod et al. VALUE IN HEALTH
- Severe Hypoglycaemia Leading to Hospital Admission in Type 2 Diabetic Patients Aged 80 Years or Older
- (2010) D. Greco et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Management of severe hypoglycaemia: cultural similarities, differences and resource consumption in three European countries
- (2009) M. Lammert et al. JOURNAL OF MEDICAL ECONOMICS
- Costs of managing severe hypoglycaemia in three European countries
- (2009) Mette Hammer et al. JOURNAL OF MEDICAL ECONOMICS
- Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France
- (2008) P. Vexiau et al. DIABETES OBESITY & METABOLISM
- Utility values for symptomatic non-severe hypoglycaemia elicited from persons with and without diabetes in Canada and the United Kingdom
- (2008) Adrian R Levy et al. Health and Quality of Life Outcomes
- How hypoglycaemia can affect the life of a person with diabetes
- (2007) Brian M. Frier DIABETES-METABOLISM RESEARCH AND REVIEWS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started